Catherine Gallagher is a Neurology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 53792
Telephone
608-263-5442Provider last certified this registry record 11 Jan 2021.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
88.8%Aromatic Amino Acid Decarboxylation Inhibitor43.7%Carbidopa-Levodopa74%Carbidopa-Levodopa Er26%Part D≥64 patientsNonergot Dopamine Agonist8.8%Pramipexole Dihydrochloride59%Ropinirole Hcl41%Part D<11 patients+ 10 more classes in this area
Cardiovascular
8.4%Beta blocker8.4%Propranolol Hcl Er61%Propranolol Hcl39%Part D<11 patientsMusculoskeletal
2.8%gamma-Aminobutyric Acid-ergic Agonist2.8%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2012–2025 per NIH RePORTER. The latest:
- Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
University of Wisconsin-Madison
FY2025$749,746R01AG082174 - Mapping Synaptic Density in Prodromal and Manifest Lewy Body Dementia
University of Wisconsin-Madison
FY2024$755,300R01AG082174 - Longitudinal MRI in Preclinical Parkinson Disease
Wm S. Middleton Memorial Veterans Hosp
FY2023I01CX000555
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”